GFM
RLAY icon

GF Fund Management’s Relay Therapeutics RLAY Stock Holding History

GF Fund Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.6K Buy
3,876
+470
+14% +$4.21K ﹤0.01% 430
2025
Q4 		$28.8K Sell
3,406
-303
-8% -$2.16K ﹤0.01% 465
2025
Q3 		$19.4K Sell
3,709
-577
-13% -$2.2K ﹤0.01% 491
2025
Q2 		$14.8K Hold
4,286
– – ﹤0.01% 528
2025
Q1 		$11.2K Buy
4,286
+771
+22% +$3.02K ﹤0.01% 552
2024
Q4 		$14.5K Buy
+3,515
New +$19.1K ﹤0.01% 502

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

GF Fund Management's RLAY Position: Q1 2026 in Review

GF Fund Management increased its Relay Therapeutics (RLAY) stake by 14% in Q1 2026, buying an estimated $4.21K and bringing the position to 3,876 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #430.

GF Fund Management first reported a position in RLAY in Q4 2024 and has held it in 6 quarters since. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • GF Fund Management held 3,876 shares of Relay Therapeutics worth $38.6K as of Q1 2026.
  • GF Fund Management bought 470 Relay Therapeutics shares in Q1 2026, an estimated $4.21K.
  • Relay Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #430 holding.
  • GF Fund Management first reported a position in Relay Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.